Torres V E, Northrup T E, Edwards R M, Shah S V, Dousa T P
J Clin Invest. 1978 Dec;62(6):1334-43. doi: 10.1172/JCI109254.
Because glomerular functions are modulated by numerous humoral agents, probably acting through cyclic nucleotides, the effects of some polypeptide hormones and biogenic amines on cyclic AMP (cAMP) and cyclic 3',5'-guanosine monophosphate (cGMP) were studied in glomeruli isolated from rat renal cortex. Glomeruli and cortical tubules were prepared by a combination of sieving and density-gradient centrifugation. Under basal conditions, the contents of cAMP and cGMP in glomeruli were significantly higher than in tubules and unfractionated renal cortical tissue.Histamine caused a striking increase in cAMP in glomeruli (+Delta% 675+/-87) and, to a lesser degree, increased cAMP in tubules (+Delta% 103+/-25) or in tissue slices. This stimulation was dose-dependent in the range of 1 muM-1 mM histamine. Metiamide (an H(2)-antagonist), but not pyrilamine (an H(1)-antagonist) blocked the effect of histamine on cAMP, which indicates that histamine causes its effect via interaction with H(2) receptors. Histamine caused less extensive increases in cGMP in both glomeruli and tubules. Carbamylcholine caused a marked increase in cGMP in glomeruli (+Delta 295+/-7) and a much lower increase in tubules (+Delta% 70+/-20); these effects were blocked by atropine. Parathyroid hormone (1 mug/ml) increased cAMP and, to a much lesser degree, also cGMP in glomeruli. In tubules, parathyroid hormone caused much more extensive increases in cAMP than in glomeruli; no changes, or rather a small decline in cGMP, was observed. Angiotensin-II (2 muM) markedly lowered cAMP in glomeruli (-Delta% -45+/-8) and in tubules (-Delta% 33+/-7) but had no effect on cGMP. Bradykinin (20 muM) did not consistently influence either cAMP or cGMP in glomeruli or tubules. Present results demonstrate that cAMP and cGMP metabolism in glomeruli are controlled independently by humoral agents known to alter glomerular functions in vivo. Our findings are consistent with the view that histamine and cholinergic agents generated and (or) released locally in glomeruli or in their vicinity may play important roles as mediators of immunopathological injury of glomeruli, and that these effects are mediated by cAMP and (or) cGMP through interaction with H(2) receptors and muscarinic receptors. Likewise, our results suggest that the effects of angiotensin-II and parathyroid hormone on glomerular dynamics may be mediated by cyclic nucleotides.Thus, we surmise that extrarenal as well as intrarenal humoral agents may play an important role in the pathology and physiology of glomeruli through mediation of either cAMP, cGMP, or both.
由于肾小球功能受到多种体液因子的调节,这些因子可能通过环核苷酸发挥作用,因此研究了一些多肽激素和生物胺对从大鼠肾皮质分离的肾小球中环磷酸腺苷(cAMP)和环3',5'-鸟苷单磷酸(cGMP)的影响。通过筛分和密度梯度离心相结合的方法制备肾小球和皮质小管。在基础条件下,肾小球中cAMP和cGMP的含量显著高于小管和未分级的肾皮质组织。组胺使肾小球中的cAMP显著增加(增加百分比675±87),在较小程度上也使小管或组织切片中的cAMP增加(增加百分比103±25)。在1 μM - 1 mM组胺范围内,这种刺激呈剂量依赖性。甲硫咪胺(一种H₂拮抗剂)而非吡苄明(一种H₁拮抗剂)可阻断组胺对cAMP的作用,这表明组胺通过与H₂受体相互作用发挥其效应。组胺使肾小球和小管中的cGMP增加幅度较小。氨甲酰胆碱使肾小球中的cGMP显著增加(增加295±7),而使小管中的增加幅度小得多(增加百分比70±20);这些效应被阿托品阻断。甲状旁腺激素(1 μg/ml)使肾小球中的cAMP增加,在较小程度上也使cGMP增加。在小管中,甲状旁腺激素使cAMP的增加幅度比在肾小球中更大;未观察到cGMP有变化,或实际上略有下降。血管紧张素II(2 μM)使肾小球和小管中的cAMP显著降低(降低百分比 - 45±8和 - 33±7),但对cGMP无影响。缓激肽(20 μM)对肾小球或小管中的cAMP或cGMP没有一致的影响。目前的结果表明,肾小球中cAMP和cGMP的代谢由已知在体内改变肾小球功能的体液因子独立控制。我们的发现与以下观点一致,即局部在肾小球或其附近产生和(或)释放 的组胺和胆碱能因子可能作为肾小球免疫病理损伤的介质发挥重要作用,并且这些效应通过cAMP和(或)cGMP与H₂受体和毒蕈碱受体的相互作用介导。同样,我们的结果表明血管紧张素II和甲状旁腺激素对肾小球动力学的影响可能由环核苷酸介导。因此,我们推测肾外和肾内体液因子可能通过介导cAMP、cGMP或两者在肾小球的病理和生理过程中发挥重要作用。